Impending Qui Tams and False Claims Act Cases Involving Health Exchanges

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know

In House Warrior with Daniel Kracov